Report Detail
Global and Japan Inactivated Vaccine Market Insights, Forecast to 2026
- RnM4175572 |
- 31 August, 2020 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Inactivated Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Inactivated Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Inactivated Vaccine market is segmented into
Children
Adult
Segment by Application, the Inactivated Vaccine market is segmented into
Hospital
Medical Center
Regional and Country-level Analysis
The Inactivated Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Inactivated Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inactivated Vaccine Market Share Analysis
Inactivated Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inactivated Vaccine business, the date to enter into the Inactivated Vaccine market, Inactivated Vaccine product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma (Japan)
CSL Limited (Australia)
Emergent BioSolutions (U.S.)
GlaxoSmithKline (U.K.)
Johnson & Johnson (U.S.)
MedImmune (U.S.)
Merck & Co (U.S.)
Pfizer (U.S.)
Sanofi Pasteur (France)
Serum Institute of India Pvt (India)
1 Study Coverage
- 1.1 Inactivated Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Inactivated Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Inactivated Vaccine Market Size Growth Rate by Type
- 1.4.2 Children
- 1.4.3 Adult
- 1.5 Market by Application
- 1.5.1 Global Inactivated Vaccine Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Medical Center
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Inactivated Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Inactivated Vaccine Revenue 2015-2026
- 2.1.2 Global Inactivated Vaccine Sales 2015-2026
- 2.2 Global Inactivated Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Inactivated Vaccine Historical Market Size by Region (2015-2020)
- 2.3.1 Global Inactivated Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Inactivated Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Inactivated Vaccine Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Inactivated Vaccine Sales Forecast by Region (2021-2026)
- 2.4.2 Global Inactivated Vaccine Revenue Forecast by Region (2021-2026)
3 Global Inactivated Vaccine Competitor Landscape by Players
- 3.1 Global Top Inactivated Vaccine Sales by Manufacturers
- 3.1.1 Global Inactivated Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Global Inactivated Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Inactivated Vaccine Manufacturers by Revenue
- 3.2.1 Global Inactivated Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Inactivated Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Inactivated Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Inactivated Vaccine Revenue in 2019
- 3.2.5 Global Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Inactivated Vaccine Price by Manufacturers
- 3.4 Global Inactivated Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Inactivated Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Inactivated Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Inactivated Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Inactivated Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Inactivated Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Inactivated Vaccine Revenue by Type (2015-2020)
- 4.1.3 Inactivated Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Inactivated Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Inactivated Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Inactivated Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Inactivated Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Inactivated Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Inactivated Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Inactivated Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Inactivated Vaccine Revenue by Application (2015-2020)
- 5.1.3 Inactivated Vaccine Price by Application (2015-2020)
- 5.2 Inactivated Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Inactivated Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Inactivated Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Inactivated Vaccine Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
- 6.1 Japan Inactivated Vaccine Market Size YoY Growth 2015-2026
- 6.1.1 Japan Inactivated Vaccine Sales YoY Growth 2015-2026
- 6.1.2 Japan Inactivated Vaccine Revenue YoY Growth 2015-2026
- 6.1.3 Japan Inactivated Vaccine Market Share in Global Market 2015-2026
- 6.2 Japan Inactivated Vaccine Market Size by Players (International and Local Players)
- 6.2.1 Japan Top Inactivated Vaccine Players by Sales (2015-2020)
- 6.2.2 Japan Top Inactivated Vaccine Players by Revenue (2015-2020)
- 6.3 Japan Inactivated Vaccine Historic Market Review by Type (2015-2020)
- 6.3.1 Japan Inactivated Vaccine Sales Market Share by Type (2015-2020)
- 6.3.2 Japan Inactivated Vaccine Revenue Market Share by Type (2015-2020)
- 6.3.3 Japan Inactivated Vaccine Price by Type (2015-2020)
- 6.4 Japan Inactivated Vaccine Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 Japan Inactivated Vaccine Sales Forecast by Type (2021-2026)
- 6.4.2 Japan Inactivated Vaccine Revenue Forecast by Type (2021-2026)
- 6.4.3 Japan Inactivated Vaccine Price Forecast by Type (2021-2026)
- 6.5 Japan Inactivated Vaccine Historic Market Review by Application (2015-2020)
- 6.5.1 Japan Inactivated Vaccine Sales Market Share by Application (2015-2020)
- 6.5.2 Japan Inactivated Vaccine Revenue Market Share by Application (2015-2020)
- 6.5.3 Japan Inactivated Vaccine Price by Application (2015-2020)
- 6.6 Japan Inactivated Vaccine Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 Japan Inactivated Vaccine Sales Forecast by Application (2021-2026)
- 6.6.2 Japan Inactivated Vaccine Revenue Forecast by Application (2021-2026)
- 6.6.3 Japan Inactivated Vaccine Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Inactivated Vaccine Market Size YoY Growth 2015-2026
- 7.2 North America Inactivated Vaccine Market Facts & Figures by Country
- 7.2.1 North America Inactivated Vaccine Sales by Country (2015-2020)
- 7.2.2 North America Inactivated Vaccine Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Inactivated Vaccine Market Size YoY Growth 2015-2026
- 8.2 Europe Inactivated Vaccine Market Facts & Figures by Country
- 8.2.1 Europe Inactivated Vaccine Sales by Country
- 8.2.2 Europe Inactivated Vaccine Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Inactivated Vaccine Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Inactivated Vaccine Market Facts & Figures by Country
- 9.2.1 Asia Pacific Inactivated Vaccine Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Inactivated Vaccine Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Inactivated Vaccine Market Size YoY Growth 2015-2026
- 10.2 Latin America Inactivated Vaccine Market Facts & Figures by Country
- 10.2.1 Latin America Inactivated Vaccine Sales by Country
- 10.2.2 Latin America Inactivated Vaccine Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Inactivated Vaccine Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Inactivated Vaccine Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Inactivated Vaccine Sales by Country
- 11.2.2 Middle East and Africa Inactivated Vaccine Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Astellas Pharma (Japan)
- 12.1.1 Astellas Pharma (Japan) Corporation Information
- 12.1.2 Astellas Pharma (Japan) Description and Business Overview
- 12.1.3 Astellas Pharma (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Astellas Pharma (Japan) Inactivated Vaccine Products Offered
- 12.1.5 Astellas Pharma (Japan) Recent Development
- 12.2 CSL Limited (Australia)
- 12.2.1 CSL Limited (Australia) Corporation Information
- 12.2.2 CSL Limited (Australia) Description and Business Overview
- 12.2.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 CSL Limited (Australia) Inactivated Vaccine Products Offered
- 12.2.5 CSL Limited (Australia) Recent Development
- 12.3 Emergent BioSolutions (U.S.)
- 12.3.1 Emergent BioSolutions (U.S.) Corporation Information
- 12.3.2 Emergent BioSolutions (U.S.) Description and Business Overview
- 12.3.3 Emergent BioSolutions (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Emergent BioSolutions (U.S.) Inactivated Vaccine Products Offered
- 12.3.5 Emergent BioSolutions (U.S.) Recent Development
- 12.4 GlaxoSmithKline (U.K.)
- 12.4.1 GlaxoSmithKline (U.K.) Corporation Information
- 12.4.2 GlaxoSmithKline (U.K.) Description and Business Overview
- 12.4.3 GlaxoSmithKline (U.K.) Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 GlaxoSmithKline (U.K.) Inactivated Vaccine Products Offered
- 12.4.5 GlaxoSmithKline (U.K.) Recent Development
- 12.5 Johnson & Johnson (U.S.)
- 12.5.1 Johnson & Johnson (U.S.) Corporation Information
- 12.5.2 Johnson & Johnson (U.S.) Description and Business Overview
- 12.5.3 Johnson & Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Johnson & Johnson (U.S.) Inactivated Vaccine Products Offered
- 12.5.5 Johnson & Johnson (U.S.) Recent Development
- 12.6 MedImmune (U.S.)
- 12.6.1 MedImmune (U.S.) Corporation Information
- 12.6.2 MedImmune (U.S.) Description and Business Overview
- 12.6.3 MedImmune (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 MedImmune (U.S.) Inactivated Vaccine Products Offered
- 12.6.5 MedImmune (U.S.) Recent Development
- 12.7 Merck & Co (U.S.)
- 12.7.1 Merck & Co (U.S.) Corporation Information
- 12.7.2 Merck & Co (U.S.) Description and Business Overview
- 12.7.3 Merck & Co (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Merck & Co (U.S.) Inactivated Vaccine Products Offered
- 12.7.5 Merck & Co (U.S.) Recent Development
- 12.8 Pfizer (U.S.)
- 12.8.1 Pfizer (U.S.) Corporation Information
- 12.8.2 Pfizer (U.S.) Description and Business Overview
- 12.8.3 Pfizer (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Pfizer (U.S.) Inactivated Vaccine Products Offered
- 12.8.5 Pfizer (U.S.) Recent Development
- 12.9 Sanofi Pasteur (France)
- 12.9.1 Sanofi Pasteur (France) Corporation Information
- 12.9.2 Sanofi Pasteur (France) Description and Business Overview
- 12.9.3 Sanofi Pasteur (France) Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Sanofi Pasteur (France) Inactivated Vaccine Products Offered
- 12.9.5 Sanofi Pasteur (France) Recent Development
- 12.10 Serum Institute of India Pvt (India)
- 12.10.1 Serum Institute of India Pvt (India) Corporation Information
- 12.10.2 Serum Institute of India Pvt (India) Description and Business Overview
- 12.10.3 Serum Institute of India Pvt (India) Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Serum Institute of India Pvt (India) Inactivated Vaccine Products Offered
- 12.10.5 Serum Institute of India Pvt (India) Recent Development
- 12.11 Astellas Pharma (Japan)
- 12.11.1 Astellas Pharma (Japan) Corporation Information
- 12.11.2 Astellas Pharma (Japan) Description and Business Overview
- 12.11.3 Astellas Pharma (Japan) Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Astellas Pharma (Japan) Inactivated Vaccine Products Offered
- 12.11.5 Astellas Pharma (Japan) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Inactivated Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Inactivated Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Inactivated Vaccine. Industry analysis & Market Report on Inactivated Vaccine is a syndicated market report, published as Global and Japan Inactivated Vaccine Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Inactivated Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
